Denna sida på svenska
Loading profile information...

About me

I am a mathematical statistician and have worked as an applied biostatistician since 2011. Since 2016 I work in the cancer epidemiology group at the Divison of Clinical Epidemiology (Department of Medicine, Solna). I am also registered as a PhD-student with Sandra Eloranta as my main supervisor and Karin Ekström Smedby and Mats Jerkeman as co-supervisors. My research topic is studying patterns and trends in the incidence, prevalence and survival as well as survivorship issues among patients diagnosed with the most common non-hodgkin lymphoma subtypes in Sweden, with a focus on Diffuse Large B-cell Lymphoma.

Publications

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S, Jerkeman M, Andersson Po, Enblad G, Wahlin Be, Hasselblom S, et al
American journal of hematology 2018;():-

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I, Eloranta S, Ekberg S, Chang Et, Neovius M, Smedby Ke
American journal of hematology 2017;92(3):251-258

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Frisk G, Tinge B, Ekberg S, Eloranta S, Bäcklund Lm, Lidbrink E, et al
Breast cancer research and treatment 2017;166(3):887-896

Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse
Everhov Åh, Ekberg S, Hirschberg Al, Bergmark K, Rådestad Af, Glimelius I, et al
Journal of cancer survivorship : research and practice 2016;10(3):514-23

What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?
Simard Jf, Ekberg S, Johansson Al, Askling J
Annals of the rheumatic diseases 2016;75(5):862-6

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L, Glimelius I, Neovius M, Ekberg S, Martling A, Eloranta S, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(6):987-94

Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study
Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang Et, Neovius M, et al
Journal of cancer survivorship : research and practice 2015;9(4):610-1

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I, Ekberg S, Jerkeman M, Chang Et, Björkholm M, Andersson Tm, et al
American journal of hematology 2015;90(12):1128-34

Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L, Glimelius I, Neovius M, Eloranta S, Ekberg S, Martling A, et al
The British journal of surgery 2015;102(11):1426-32

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment
Nord C, Olofsson Se, Glimelius I, Cedermark Gc, Ekberg S, Cavallin-ståhl E, et al
Acta oncologica (Stockholm, Sweden) 2015;54(10):1770-80

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study
Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang Et, Neovius M, et al
Journal of cancer survivorship : research and practice 2015;9(4):599-609

Familial effects on survival after myocardial infarction: a registry-based sib-pair study
Ekberg S, Ploner A, De Faire U, Pedersen Nl, Bennet Am
European journal of epidemiology 2012;27(12):911-4

Show all publications

Map